Adenosine A2a Receptor Antikörper (C-Term)

Produktnummer ABIN929402

Der Kaninchen Polyklonal Anti-Adenosine A2a Receptor-Antikörper wurde für WB validiert. Er ist geeignet, Adenosine A2a Receptor in Proben von Human zu detektieren.

Kurzübersicht für Adenosine A2a Receptor Antikörper (C-Term) (ABIN929402)

Target: Adenosine A2a Receptor (ADORA2A)

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Adenosine A2a Receptor Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Produktdetails anti-Adenosine A2a Receptor Antikörper

Bindungsspezifität: C-Term

Aufreinigung: Purified

Immunogen: ADORA2 A antibody was raised in rabbit using the C terminal of ADORA2 as the immunogen

Anwendungsinformationen

Applikationshinweise: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Kommentare:

ADORA2A Blocking Peptide, (ABIN5611957), is also available for use as a blocking control in assays to test for specificity of this ADORA2A antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Details zu Adenosine A2a Receptor

Target: Adenosine A2a Receptor (ADORA2A)

Andere Bezeichnung: ADORA2A

Hintergrund: ADORA2A is one of several receptor subtypes for adenosine. The activity of the protein, a G-protein coupled receptor family member, is mediated by G proteins which activate adenylyl cyclase. ADORA2A is abundant in basal ganglia, vasculature and platelets and it is a major target of caffeine. Synonyms: Polyclonal ADORA2A antibody, Anti-ADORA2A antibody, adenosine A2a receptor antibody, ADORA2 antibody, RDC8 antibody, hA2aR antibody.

Pathways: Neurotrophin Signalübertragung, cAMP Metabolic Process, Synaptic Membrane, Feeding Behaviour, Cancer Immune Checkpoints